Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
201-500
employees, estimated range
Backers
1
Lux Capital
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 2025 Website went live first capture in the Wayback Machine
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Vanqua BioVenture round $45M · 2 yr ago • Founded 2019 • 201-500 employees
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
VectoryTxFounded 2020 • 51-200 employees • 1 role
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
PronirasVenture round $6.9M · 2 yr ago • Founded 2016 • 11-50 employees
About Us Proniras Corporation ("Proniras") is a clinical-stage biotechnology company focused on the development of novel small-molecule…
Monument BiosciencesVenture round $5.8M · 3 yr ago • Founded 2018 • 11-50 employees
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.
Atavistik BioSeries B $120M · 10 mo ago • Founded 2021 • 51-200 employees • 1 role
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…
NeurocarrusFounded 2017 • 11-50 employees
What is Neurocarrus?Treating Neurodegenerative Disease and Pain Without Addiction.Neurocarrus is a biotech company developing a novel drug…

Overview

Advancing medicines to restore homeostasis. Cajal Therapeutics is developing novel medicines for serious diseases, including anemias of inflammation, neurodegenerative diseases, and other iron-related disorders.